Visas open door to increased US FDA drug inspections in China
This article was originally published in Scrip
Executive Summary
China's decision to finally grant visas to enable an increase in the number of US FDA drug inspectors stationed in the country apparently marks a willingness to open up its pharmaceutical manufacturing activities to wider outside scrutiny.